SIOP Asia in Mongolia Was a Great Success
15 Posts Not To Miss From ASCO Breakthrough 2026
Guatemala Officially Enacts New Regulation for Comprehensive Cancer Care
Oncology Community Welcomes Two New FDA Approvals for Breast Cancer
Gold After Cancer: Summer Olympians Who Returned to Win Medals
Liang Cheng: Transforming the Treatment Landscape of Urothelial Carcinoma
Inside DeepHealth: How RadNet's AI Bet Is Reshaping the Business of Radiology
T-Bren Shows Early Activity Across HER2-Positive and HER2-Low Advanced Breast Cancer
Tracks percentage of skeletal tumor burden and change from baseline in metastatic bone disease. Designed for longitudinal monitoring and documentation of disease trend.
Trend thresholds: Stable within ±10% of baseline | Increase >10% | Decrease >10%
